Atthaphong Phongphithakchai
Overview
Explore the profile of Atthaphong Phongphithakchai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phongphithakchai A, Bellomo R, Mount P, Bach C, Gurry G, Liu W, et al.
Am J Nephrol
. 2025 Jan;
:1-12.
PMID: 39809227
Introduction: Angiotensin II may reduce muscle ischemia during intermittent hemodialysis (IHD) and thereby decrease the incidence and/or intensity of intradialytic muscle cramps. We aimed to test whether angiotensin II infusion...
2.
Pattamin N, Phongphithakchai A, Spano S, Maeda A, Chaba A, Hikasa Y, et al.
Crit Care Resusc
. 2025 Jan;
26(4):286-294.
PMID: 39781496
Objective: To assess current evidence regarding guanfacine use in hospitalized patients with delirium. Introduction: Delirium is a common and important complication of critical illness. Central alpha-2 agonists are often used...
3.
Chaba A, Phongphithakchai A, Pope O, Rajapaksha S, Ranjan P, Maeda A, et al.
Crit Care Resusc
. 2025 Jan;
26(4):311-318.
PMID: 39781493
Background: Severe intensive care unit-acquired hypernatraemia (ICU-AH) is a serious complication of critical illness. However, there is no detailed information on how this condition develops. Objectives: The objective of this...
4.
Maeda A, Brown A, Spano S, Chaba A, Phongphithakchai A, Hikasa Y, et al.
J Crit Care
. 2024 Dec;
86:155002.
PMID: 39689380
Purpose: Furosemide is the most commonly used diuretic in intensive care units (ICU). We aimed to evaluate the physiological effects of adjunctive acetazolamide with furosemide on diuresis and the prevention...
5.
Chaba A, Warrillow S, Fisher C, Spano S, Maeda A, Phongphithakchai A, et al.
Blood Purif
. 2024 Nov;
54(2):111-121.
PMID: 39561725
Introduction: Paracetamol (acetaminophen)-induced acute liver failure (ALF) with severe hyperammonemia (ammonia >100 µmol⋅L-1) is a life-threatening condition. A strategy based on high-intensity continuous renal replacement therapy (CRRT) without early (up...
6.
Indo H, Chatatikun M, Nakanishi I, Matsumoto K, Imai M, Kawakami F, et al.
Biomolecules
. 2024 Oct;
14(10).
PMID: 39456251
The universe began 13.8 billion years ago, and Earth was born 4.6 billion years ago. Early traces of life were found as soon as 4.1 billion years ago; then, ~200,000...
7.
Dandecha P, Phongphithakchai A
Iran J Kidney Dis
. 2024 Oct;
18(4):212-220.
PMID: 39423095
Introduction: Peritoneal dialysis utilizes two distinct double-bag exchange systems (ANDY-Disc from Fresenius Medical Care in Bad Homburg, Germany, and DIANEAL from Baxter in Deerfield, IL). These systems are widely used...
8.
Chatatikun M, Tedasen A, Phinyo P, Wongyikul P, Klangbud W, Kawakami F, et al.
Front Pharmacol
. 2024 Oct;
15:1472419.
PMID: 39415841
Background: Diabetes mellitus is a significant global health issue, and alternative treatments from natural products like L. [Clusiaceae] or GM are being explored for their potential benefits. This study focused...
9.
Chatatikun M, Indo H, Imai M, Kawakami F, Kubo M, Kitagawa Y, et al.
Front Pharmacol
. 2024 Oct;
15:1452616.
PMID: 39391697
This review discusses the prevention and treatment of coronavirus disease 2019 (COVID-19) caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Mutations in its spike glycoprotein have...
10.
Phongphithakchai A, Maeda A, Hikasa Y, Spano S, Pattamin N, Chaba A, et al.
Biomark Med
. 2024 Sep;
18(19):823-830.
PMID: 39269846
Higher nitric oxide (NO) levels correlate with adverse sepsis outcomes but are challenging to measure. Methemoglobin (MetHb), a measurable product of NO, has not been utilized for risk stratification. All...